Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

AH-001 could be a safer and more effective treatment for hair loss.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.